Dr. Eric Padrone, a hematologist from H. Lee Moffit Cancer Center, discusses current thinking on MDS/MPN overlap disorders and myelofibrosis.
The following questions are answered:
What are MDS/MPN overlap disorders? (CMML, etc.)
What is myelofibrosis? What are the current treatments for MDS/MPN overlap and myelofibrosis?
What treatments or treatment approaches are coming in the future? What might these mean for patients?
This video was recorded at the Aplastic Anemia and MDS International Foundation's Scientific Symposium in March, 2018.
Related Content:
Zegfrovy FDA Approved for EGFR Exon 20 Non-Small Cell Lung Cancer
This Wasn’t the Plan: My Mother and Her Silence
Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission
Tipping My Hat to the Heroes of the Cancer Community
